[A new model of adrenergic nerve termination].
D000818:Animals; D002415:Cats; D004299:Dopamine beta-Hydroxylase / Q000502:physiology; D007001:Hypogastric Plexus / Q000187:drug effects / Q000502:physiology; D008026:Ligation; D008959:Models, Neurological; D009411:Nerve Endings / Q000187:drug effects / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology; D011813:Quinuclidinyl Benzilate / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D011976:Receptors, Muscarinic / Q000502:physiology; D009435:Synaptic Transmission; D014701:Veratridine / Q000494:pharmacology
D011942:Receptors, Adrenergic, alpha; D011976:Receptors, Muscarinic; D011813:Quinuclidinyl Benzilate; D014701:Veratridine; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine
Un nuevo modelo de terminación nerviosa adrenérgica.